RECRUITING

Neural Mechanisms of Immersive Virtual Reality in Chronic Pain (VR TMD EEG)

Talk to us

Conditions

PainVirtual RealityPlaceboTemporomandibular DisorderTMD volunteersVRClinical PainEcological Momentary Assessment

Quick Navigation

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

This project examines, in chronic pain, the mechanisms of immersive virtual reality compared to the mechanisms of placebo hypoalgesia. The potential of developing new non-pharmacological premises for low-risk interventions for pain management is high.

Official Title

Neural Mechanisms of Immersive Virtual Reality in Chronic Pain

Quick Facts

Study Start:2024-04-09
Study Completion:2026-09
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT06214923

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:18 Years to 88 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:No
Standard Ages:ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. * Age (18-88 years)
  2. * English speaker (written and spoken)
  3. * Temporal Mandibular Disorder (TMD) for at least 3 months
  4. * TMD Grade Chronic Pain Scale (GCPS) ≥ 0
  1. * Present or past degenerative neuromuscular disease
  2. * Cardiovascular, neurological diseases, pulmonary abnormalities, kidney disease, liver disease, history of cancer within past 3 years
  3. * Cervical pain (e.g. stenosis, radiculopathy)
  4. * Any personal (or family first degree) history of mania, schizophrenia, or other psychoses
  5. * Severe psychiatric condition (e.g. schizophrenia, bipolar disorders, autism) leading to hospitalization within the last 3 years.
  6. * Use of Antipsychotics (e.g., Risperdal, Ability and clozaril)Lifetime alcohol/drug dependence or alcohol/drug abuse in past 3 months
  7. * Pregnancy or breast feeding
  8. * Color-blindness
  9. * Impaired or uncorrected hearing
  10. * Non-dominant hand
  11. * Any facial trauma that has occurred in the last 6 weeks
  12. * History of a severe facial trauma in the last 2-3 months
  13. * Conditions that would interfere with the VR mask placement (e.g. trauma, burn, infection)
  14. * Known history of severe motion sickness
  15. * Non-removable head cover, artificial hair, certain types of braids or dreadlocks
  16. * History of fainting
  17. * History of angioedema
  18. * Failed drug test (testing for opiates, cocaine, methamphetamines, and amphetamines)

Contacts and Locations

Study Contact

Research Coordinator
CONTACT
410-706-5975
NRSCollocaLab@umaryland.edu
Katia Matychak, MS
CONTACT
410-706-5975
katiamatychak@umaryland.edu

Study Locations (Sites)

Luana Colloca
Baltimore, Maryland, 21201-1512
United States
University of Maryland
Baltimore, Maryland, 21201-1512
United States

Collaborators and Investigators

Sponsor: University of Maryland, Baltimore

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2024-04-09
Study Completion Date2026-09

Study Record Updates

Study Start Date2024-04-09
Study Completion Date2026-09

Terms related to this study

Keywords Provided by Researchers

  • TMD volunteers
  • VR
  • Clinical Pain
  • Ecological Momentary Assessment

Additional Relevant MeSH Terms

  • Pain
  • Virtual Reality
  • Placebo
  • Temporomandibular Disorder